ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Breo Ellipta (GlaxoSmithKline/Innoviva) Drug Analysis 2018
March 30, 2018Breo Ellipta (GlaxoSmithKline/Innoviva) is a combination of fluticasone furoate and vilanterol indicated for the treatment of asthma and chronic obstructive pulmonary disorder. -
Natrecor (nesiritide; Johnson & Johnson) Drug Analysis 2018
March 30, 2018Natrecor is used to treat patients with acute decompensated heart failure (ADHF) who have difficulty breathing or have minimal activity during rest. -
Spiriva (tiotropium; Boehringer Ingelheim) Drug Analysis 2018
March 30, 2018Spiriva is a long-acting muscarinic antagonist (LAMA) approved for use in chronic obstructive pulmonary disease and is available in a dry-powder inhale and soft mist inhaler (Respimat) device.
Pharma Sources Insight January 2025
